Elekta wins lawsuit against Livian GmbH

STOCKHOLM, March 8, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that the London Court of International Arbitration (LCIA) has awarded in favor of Elekta in a dispute with Livian GmbH (formerly humediQ GmbH).

The arbitration, reported in the latest interim report (Q3 2020/21), is now finally settled whereby all claims against Elekta group companies are rejected in full.

For further information, please contact:Mattias Thorsson, VP Corporate CommunicationsTel: +46 70 865 8012, e-mail: [email protected]  Time zone: CET: Central European Time

Cecilia Ketels, Head of Investor RelationsTel: +46 76 611 76 25, e-mail: [email protected]Time zone: CET: Central European Time

About ElektaFor almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/elekta/r/elekta-wins-lawsuit-against-livian-gmbh,c3301556

The following files are available for download:

View original content:http://www.prnewswire.com/news-releases/elekta-wins-lawsuit-against-livian-gmbh-301242178.html

SOURCE Elekta